Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - TOTAL CURRENT LIABILITIES
Total Current Liabilities ALNY - Alnylam Pharmaceuticals, Inc.
1.19 B
LAST VALUE
24.29%
2 YEAR CAGR
4.40%
5 YEAR CAGR
23.53%
10 YEAR CAGR